Glooko

We’re excited to share the latest updates included in Glooko Web 25.4 and Glooko Mobile 6.14, which are designed to help healthcare providers and care teams move faster with easier-to-understand risk insights, while also making it easier for people living with diabetes to connect devices and apps and remotely share data with their care teams.

Enhancements to the Glooko Clinic Dashboard

The Glooko clinic dashboard, designed to improve diabetes population health management and available in select countries, now features enhanced usability and accuracy improvements, making risk insights clearer for faster action across clinics, hospitals, and health systems.

Other enhancements to our population health tool include:

Clearer risk visibility: An updated Time in Range layout makes low and very low glucose risk easier to identify at a glance.
Smarter patient ranking: Patients with diabetes are prioritized by risk category, then by severity of the triggering metric.
More precise metrics: Risk indicators are displayed with greater precision for clearer comparison and trend tracking.

More Efficient Patient Review in the Glooko Web App

The patient list in the Glooko Web App for healthcare providers has been enhanced to support faster, more efficient workflows and smoother navigation.

Care teams can now see more patient data at once with a wider default view that reduces horizontal scrolling, sort patients better with improved cues that make patient order easier to understand, and see key context through a revised header that stays visible as they scroll through the list.

Streamlined Clinical Workflows with Full Glooko Access in Epic

Healthcare providers using Patient Portal for Professionals can now access the full Glooko Web App directly within the Epic EHR system using SSO via SMaRT on FHIR, reducing platform switching and streamlining daily workflows.

Some of the benefits of this helpful enhancement include launching our diabetes management platform without leaving the EHR or logging in again, the use of core features including the clinic dashboard, patient list, and device assignment within Epic, faster review and action using key patient diabetes data, and reduced clinician burnout from not context switching.

If your clinic is interested in this feature, please email [email protected].

Simplified Device and App Management for People with Diabetes

Managing diabetes and health monitoring devices and apps is now quicker and intuitive in the Glooko Mobile App.

Our newly enhanced search and smarter filtering, better device categorization, and refreshed visuals, including logos, make it easier for people with diabetes to find and connect their devices and apps with fewer clicks. The update also features shortcuts to speed up Glooko’s seamless integration with more than 200 compatible diabetes and health monitoring devices and apps. Once connected, patient data can be securely shared remotely with care teams who can make more informed treatment decisions.

More Information on the Latest Glooko Release

To learn more about these updates, check out the full release notes on our Support Center or reach out to your dedicated Glooko Customer Success Manager.

Team Glooko will be at the American Diabetes Association’s 2026 Clinical Update Conference from February 6 to 8 in Houston, Texas, showcasing how our inpatient and outpatient solutions are helping hospitals and health systems address the growing challenge of glycemic safety and diabetes management and advancing team-based diabetes care.

Through our recent acquisition of Monarch Medical Technologies, we are now uniquely positioned to reduce glycemic risk, improve patient safety, and support overburdened clinical teams through coordinated expertise across the full continuum of care.

Here’s what you can learn about the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, at booth 17.

How to move from data overload to workflows that actually work: Disconnected systems, manual PDFs, and multiple logins slow care teams down and increase risk. Our EHR-integrated diabetes workflows in Glooko and EndoTool reduce manual burden, improve visibility, and enable consistent care across clinical, education, and operational teams.
Methods for preparing for mandatory CMS glycemic reporting: Hospitals are preparing for mandatory severe hypo- and hyperglycemia reporting from the Centers for Medicare & Medicaid Services. EndoTool, our patient-specific insulin dosing system, helps hospitals achieve unmatched clinical outcomes, reduce variability, and support CMS readiness with confidence.
Ways we align with the 2026 ADA Standards of Care: We’re helping clinicians and health systems turn the American Diabetes Association’s 2026 Standards of Care into reality. By streamlining data, enhancing team-based diabetes care, and delivering actionable insights, we’re bridging the gap between clinical guidelines and measurable outcomes to improve life for patients and their healthcare providers.
Tools for improving diabetes population health management: Designed for busy diabetes care team members, Glooko’s user-friendly clinic dashboard, now available in select countries, provides quick insights into patient trends and key clinic metrics to help clinics, hospitals, and health systems achieve better enterprise-wide diabetes management.

Leverage the power of team-based diabetes care

Schedule a demo with one of our experts at the ADA Clinical Update to see how your team can benefit from our innovative digital health platforms.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

Every year, the American Diabetes Association (ADA) updates its Standards of Care in Diabetes, the clinical foundation that guides how we screen, diagnose, manage, and support people living with diabetes. The 2026 guidelines are among the most comprehensive to date, with a clear message: diabetes care must evolve to meet rising complexity, widening gaps in care, and the growing urgency to improve outcomes across entire populations.

This year’s recommendations underscore that our work in connected care has never been more important.

Population health requires stronger systems, better data, and integrated teams

The Standards highlight that population health is not simply a measurement framework, but rather a commitment to improving outcomes for groups of people who experience very different barriers, risks, and trajectories. The ADA emphasizes team-based, patient-specific care, timely treatment decisions, reliable data metrics to track quality, and a culture of continuous improvement across health systems.

These priorities mirror what clinicians experience every day: fragmented systems, variable follow-up, and the challenge of navigating high-risk patients without the right tools or insights. Platforms like Glooko, which provide timely insights, structured data access, clinical integration directly into the EHR, and simplified workflows, play a direct role in enabling the proactive care models the ADA calls for. When healthcare professionals manage a large population of patients with diabetes, they often lack a clear, organized, and comprehensive view of patients’ pertinent health data.

To help address this challenge, we designed the new clinic dashboard in the Glooko diabetes management platform. This is critical in providing insights into metabolic factors and indications of clinical risk to facilitate shared decision making conversations in a personalized way, with patients and their support systems.This patient-centric approach helps healthcare providers–including primary care providers, endocrinologists, and nurses, at hospitals, health systems, and clinics–provide individualized care recommendations that are patient-specific.

The Population Metrics section of the new Glooko clinic dashboard helps care teams understand the overall health and engagement of their clinic’s patient population in a centralized and concise view. By centralizing population-level metrics, care teams can more quickly identify disengaged patients, prioritize outreach, and intervene earlier, supporting both quality goals and clinic efficiency.

Glycemic management is becoming more nuanced and more actionable

The 2026 Standards reinforce the importance of individualized glycemic assessment. A1C remains central, but ADA again stresses the clinical value of time in range (TIR), time below range (TBR), and continuous glucose monitoring (CGM) metrics for real-time, person-centered care. We observed similar trends in our 2025 Annual Diabetes Report.

For many clinicians, the challenge is not whether to use CGMs, it’s how to interpret data efficiently and translate trends into action. This is where connected, device-agnostic platforms are essential. Having glucose data delivered in clinically meaningful formats, integrated with insulin dosing, meals, and activity, allows teams to identify risks earlier, adjust therapy faster, and support patients between visits.

This is especially critical for populations highlighted in the Standards: individuals facing food or housing insecurity, young adults with rising complication rates, rural communities with limited access, and older adults with shifting needs. Digital tools do not replace clinicians; they expand their reach.

Inpatient glycemic safety: Operationalizing the ADA’s call for safer insulin use

The 2026 Standards dedicate significant space to preventing hypoglycemia, hyperglycemia, and hyperglycemic crises, events that disproportionately impact people with diabetes during hospitalization or acute illness. ADA guidance reinforces the need for:

Structured insulin protocols
Frequent monitoring to adjust dosing
Systems that minimize variation in clinical decision-making
Approaches that reduce risk during periods of physiologic instability

This is exactly where EndoTool, developed by Monarch Medical Technologies, a Glooko Company, plays a transformative role. EndoTool brings advanced, patient-specific insulin dosing to inpatient settings, enabling dynamic adjustments based on each patient’s evolving physiology. By reducing glycemic variability and supporting timely identification of trends, EndoTool aligns directly with ADA recommendations around individualized glycemic targets, hypoglycemia prevention, and safer transitions of care.

As health systems work to connect inpatient and outpatient data streams, as the Standards increasingly encourage, EndoTool and Glooko have the potential to create a more actionable ecosystem. Patients leave the hospital with a more stable glycemic trajectory, and outpatient teams gain a clearer picture of what occurred during admission, supporting smoother recovery and reduced readmissions.

A vision aligned with where diabetes care is going

Across all 2026 recommendations, a single theme stands out: better outcomes depend on proactive, connected, team-based, data-driven care. The Standards call for more timely therapy changes, broader Diabetes Self-Management Education and Support (DSMES) access, stronger telehealth offerings, and improved system-level accountability.

At Glooko, we’re proud to support clinicians and health systems in delivering on those goals by making diabetes data easier to use, helping teams coordinate more effectively, and empowering people with diabetes with insights that fit their daily lives.

The work ahead is significant, but the path is clearer than ever. Together, we can turn these standards into sustained, measurable improvements in the health of patients and the clinician experience.

Last month, I had the opportunity to attend the IHI Forum, an annual conference that brings together passionate healthcare professionals interested in advancing quality improvement, patient safety, and closing care gaps together. I was inspired by the many ideas shared during keynotes, sessions, and workshops tied to the theme of transforming healthcare by increasing safety, reducing complication severity, and improving sustainability.

My biggest takeaway: the conversation around ROI in healthcare is shifting toward acknowledging that the strongest ROI comes from prioritizing safety and outcomes. When care is safer and complications are reduced, cost savings naturally follow.

The many insights made me think about how digital health technologies, like the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, can create real, measurable value for hospitals and health systems.

Implementing Digital Solutions to Reduce Costs and Clinical Overhead

To achieve meaningful financial impact, healthcare organizations can map value streams directly to clinical outcomes, an effort that has become very common across the healthcare industry. By improving patient outcomes and reducing the incidence and severity of glycemic events through timely intervention, healthcare providers can shift their focus toward cost avoidance.

This cost-cutting effort is primarily achieved by reducing the frequency of high-cost events like diabetic ketoacidosis (DKA) or severe hypoglycemia, both proven to be reduced through use of the EndoTool inpatient platform, and mitigating the severity of complications. These improvements not only protect patient health, but also significantly lower the financial burden associated with emergency hospitalizations.

From an operational perspective, broader adoption of digital health solutions that integrate seamlessly into EHR systems, like Glooko and EndoTool, drive revenue by minimizing administrative burden and eliminating the physical costs of traditional paper-based documentation. This transition supports a smaller carbon footprint while streamlining Diagnostic Related Group (DRG) cost structures. By automating data entry and refining monitoring systems, hospitals can reduce manual labor hours, alleviate the hidden costs of alarm fatigue, and successfully decrease the average Length of Stay (LOS) for patients.

Advancing Innovation for Better Health Outcomes

In the landscape of modern healthcare rankings, the severity of patient complications has become a defining metric, often accounting for a significant portion of the evaluation of hospitals in reports like U.S. News & World Report’s annual Best Hospital rankings.

To address this, healthcare providers must look beyond basic data collection and focus on innovative digital health tools that actively mitigate these risks. For example, hospital readmissions could be reduced when healthcare providers are issued remote monitoring alerts based on trends in a patient’s health. Doctors may also shorten hospital stays if they have the ability to remotely monitor vitals.

By integrating capabilities like remote monitoring in the Glooko diabetes management platform, clinics can demonstrate a measurable reduction in the severity of outcomes, providing a safer patient experience while potentially strengthening their standing in critical industry benchmarks, including the CMS Overall Hospital Quality Star Rating and Newsweek’s “America’s Best-In-State Hospitals.”

Real impact starts with a deep dive into existing workflows to find and fix hidden gaps in diabetes care. Care teams can map out the root causes of care gaps and pinpoint exactly where digital solutions can bridge them. For instance, Glooko’s acquisition of Monarch Medical Technologies will help bridge the gap between inpatient glycemic management and outpatient diabetes care in the future. This future state, advancing continuity of care, can create a more unified ecosystem that manages diabetes holistically and helps ensure no patients feel isolated in their journey.

Improving the Patient, Family, and Staff Experience

To define success beyond traditional clinical metrics, the focus of ROI must shift toward the holistic quality of life for patients in the hospital or at home and their families.

Our solutions aim to improve the patient experience by shortening hospital stays and fostering a more restorative healing environment. By proactively managing glycemic health and reducing the severity of acute events, we allow patients and their caregivers to focus on recovery and living their life day-to-day rather than the stress of a potential health crisis.

We truly believe clinicians should spend more time with patients and less time with paperwork. That’s why we’ve designed our glycemic and diabetes management solutions with the care teams in mind. By automating data flows and simplifying complex glycemic management, we remove the “manual logistics” and heavy cognitive load that lead to burnout and reduce patient safety.

This efficiency doesn’t just improve the bottom line but could help prevent expensive complications like DKA and severe glycemic events. It creates a sustainable work environment where care teams feel empowered to provide high-value, compassionate care without being tethered to a screen.

Furthering Sustainable Practices through EHR Integrations

Sustainability and person-centered care are inseparable as it is critical we focus on the holistic well-being of the patient and their community.

Sustainability has transitioned from an elective corporate responsibility to a core operational mandate for healthcare executives. For leadership, prioritizing sustainable practices is not just about environmental stewardship. It is a strategic lever for improving patient outcomes, ensuring long-term financial viability and fulfilling the mission of “first, do no harm.”

By digitizing workflows and leveraging built-in EHR integrations, hospitals and clinics can move away from paper-heavy documentation, significantly reducing paper waste and recycling expenses. This transition doesn’t just lower operational costs as it also shrinks the carbon footprint of the practice, aligning financial savings with environmental sustainability.

Glooko and EndoTool help healthcare providers slash overheads by eliminating the physical and environmental burdens of traditional diabetes management through the solutions’ EHR integrations, future-proofing sustainability efforts.

Ready for a Glimpse into the Cost-Efficient Future of Diabetes Care?

Connect with a Glooko rep today to learn how our diabetes and glycemic management solutions can help reduce your costs, while improving health outcomes.

As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

We are proud to share that Glooko has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology Companies of 2025. This honor reflects the progress we are making toward building a more connected, personalized, and accessible future for people with diabetes and the clinicians who support them.

Each year, this list highlights organizations that are shaping the trajectory of healthcare through innovation and meaningful impact. For Glooko, this recognition reinforces the work taking place across our teams to simplify the complexity of diabetes care. Whether it is bringing data from devices into a single platform, supporting timely clinical decision making, or expanding digital tools that help people manage their diabetes with confidence, our mission has remained constant. We aim to improve patient outcomes through connected care platforms that work in the real world.

This award also reflects how far we have come in strengthening our portfolio. From the continued evolution of the Glooko platform, to the future integration of the inpatient insulin dosing technology of EndoTool, developed by Monarch Medical Technologies, a Glooko Company, to our partnerships that expand clinical value and accessibility, we are building an innovative approach to diabetes management that spans the full care journey. These advancements are the direct result of our teams’ expertise and commitment to the people who rely on our products every day.

Most importantly, this recognition is a reminder of why we do this work. Behind every data point is a person managing a lifelong condition while balancing the demands of life, family, and care. Our responsibility is to meet them where they are with tools that are intuitive, reliable, and informed by real clinical needs.

We are honored to be included among so many forward-thinking healthcare technology leaders. As we look to 2026, we remain focused on delivering solutions that empower clinicians, support health systems, and make life better for people with diabetes around the world.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.

During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.

Here’s what we’ll showcase at DTC25:

New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.

Elevate your practice with our innovative diabetes management platform

Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.

At Glooko, we believe that people living with diabetes are the ultimate experts in their own care. This driving principle is the heartbeat of our mission and is deeply woven into our company culture. Nowhere is this more evident than in our diabetes-focused employee resource group (ERG), the Glucose Gladiators. They ensure we live our mission daily by putting the voice of the user at the center of innovation, driving us to improve diabetes care.

Embedding Real-World Diabetes Perspectives into Glooko

Recognizing the critical need to embed real-world experience into our work, a group of employees living with diabetes came together to found the Glucose Gladiators, a vibrant internal community dedicated to connection and support. The ERG is remarkably diverse, including people with Type 1 and 2 diabetes, caregivers, former nurses and healthcare providers, and women who experienced gestational diabetes. Their firsthand perspectives are our greatest asset. By sharing their personal experiences, Glooko is better equipped as a company to create a diabetes management solution that truly resonates and fulfills our core mission.

The ERG’s purpose is to:

Educate other employees at Glooko about the realities of life with diabetes.
Foster cross-department collaboration that drives meaningful impact in diabetes care.
Help evolve our diabetes management platform to better serve the real-world needs of our users. By sharing their personal insights with our product team, we ensure our platform truly makes a difference.

Inside Look at the Glucose Gladiators’ Mission and Initiatives

Want to hear firsthand about the Glucose Gladiators’ impact? Meet Hadley Horton, a Senior Partner Manager at Glooko and a proud member of our ERG. Having lived with Type 1 diabetes since 2009, Hadley shares how the group’s personal experiences fuel their passion for improving the lives of others in the diabetes community.

MKT-0467

Healthcare providers struggle to manage large diabetes populations without a comprehensive view of patient data.

During this webinar, Glooko Chief Medical and Strategy Officer Mark Clements, MD, PhD, and Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, explore the new Glooko clinic dashboard, a powerful tool designed to streamline diabetes population health management and enable smarter care across hospitals, health systems, and clinics.

Our clinical experts take a deep dive into this user-friendly dashboard, available in select countries, and showcase its at-a-glance insights into patient trends and key clinic metrics that can help care teams easily interpret complex data for more efficient decision-making.

Ready to optimize diabetes population health management?

Contact Team Glooko for a demo of our new clinic dashboard, which helps healthcare teams manage large diabetes populations more effectively by prioritizing care and boosting patient engagement.

MKT-0468